Product
TIL
4 clinical trials
7 indications
Indication
Solid TumorsIndication
AdultIndication
Recurrence TumorIndication
Metastatic CancerIndication
Solid TumorIndication
Ovarian CancerIndication
SarcomaClinical trial
A Single-arm Phase I Clinical Study of TIL Injection for the Treatment of Metastatic or Recurrent Solid TumorsStatus: Recruiting, Estimated PCD: 2024-04-21
Clinical trial
Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Solid TumorStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
T-cell Therapy in Combination With Checkpoint Inhibitors for Patients With Advanced Ovarian-, Fallopian Tube- and Primary Peritoneal CancerStatus: Completed, Estimated PCD: 2020-06-01
Clinical trial
A Phase I Trial of Lymphodepletion Plus Adoptive Cell Therapy With High-Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue SarcomaStatus: Active (not recruiting), Estimated PCD: 2023-05-26